purchase customization

1 Study Coverage
1.1 Ulcerative Colitis Immunology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Ulcerative Colitis Immunology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adalimumab
1.2.3 Certolizumab Pegol
1.2.4 Tofacitinib
1.2.5 Etanercept
1.2.6 Golimumab
1.2.7 Abatacept
1.2.8 Infliximab
1.2.9 Others
1.3 Market by Application
1.3.1 Global Ulcerative Colitis Immunology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Crohn's Disease(CD)
1.3.4 Ankylosing Spondylitis(AS)
1.3.5 Psoriasis(Ps)
1.3.6 Ulcerative Colitis(UC)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ulcerative Colitis Immunology Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Ulcerative Colitis Immunology Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Ulcerative Colitis Immunology Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ulcerative Colitis Immunology Drugs Sales by Region
2.4.1 Global Ulcerative Colitis Immunology Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Ulcerative Colitis Immunology Drugs by Region (2023-2028)
2.5 Global Ulcerative Colitis Immunology Drugs Revenue by Region
2.5.1 Global Ulcerative Colitis Immunology Drugs Revenue by Region (2017-2022)
2.5.2 Global Ulcerative Colitis Immunology Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ulcerative Colitis Immunology Drugs Sales by Manufacturers
3.1.1 Global Top Ulcerative Colitis Immunology Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Ulcerative Colitis Immunology Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ulcerative Colitis Immunology Drugs in 2021
3.2 Global Ulcerative Colitis Immunology Drugs Revenue by Manufacturers
3.2.1 Global Ulcerative Colitis Immunology Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ulcerative Colitis Immunology Drugs Revenue in 2021
3.3 Global Ulcerative Colitis Immunology Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ulcerative Colitis Immunology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ulcerative Colitis Immunology Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ulcerative Colitis Immunology Drugs Sales by Type
4.1.1 Global Ulcerative Colitis Immunology Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Ulcerative Colitis Immunology Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2028)
4.2 Global Ulcerative Colitis Immunology Drugs Revenue by Type
4.2.1 Global Ulcerative Colitis Immunology Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Ulcerative Colitis Immunology Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Ulcerative Colitis Immunology Drugs Price by Type
4.3.1 Global Ulcerative Colitis Immunology Drugs Price by Type (2017-2022)
4.3.2 Global Ulcerative Colitis Immunology Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ulcerative Colitis Immunology Drugs Sales by Application
5.1.1 Global Ulcerative Colitis Immunology Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Ulcerative Colitis Immunology Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2028)
5.2 Global Ulcerative Colitis Immunology Drugs Revenue by Application
5.2.1 Global Ulcerative Colitis Immunology Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Ulcerative Colitis Immunology Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Ulcerative Colitis Immunology Drugs Price by Application
5.3.1 Global Ulcerative Colitis Immunology Drugs Price by Application (2017-2022)
5.3.2 Global Ulcerative Colitis Immunology Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ulcerative Colitis Immunology Drugs Market Size by Type
6.1.1 North America Ulcerative Colitis Immunology Drugs Sales by Type (2017-2028)
6.1.2 North America Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2028)
6.2 North America Ulcerative Colitis Immunology Drugs Market Size by Application
6.2.1 North America Ulcerative Colitis Immunology Drugs Sales by Application (2017-2028)
6.2.2 North America Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2028)
6.3 North America Ulcerative Colitis Immunology Drugs Market Size by Country
6.3.1 North America Ulcerative Colitis Immunology Drugs Sales by Country (2017-2028)
6.3.2 North America Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ulcerative Colitis Immunology Drugs Market Size by Type
7.1.1 Europe Ulcerative Colitis Immunology Drugs Sales by Type (2017-2028)
7.1.2 Europe Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2028)
7.2 Europe Ulcerative Colitis Immunology Drugs Market Size by Application
7.2.1 Europe Ulcerative Colitis Immunology Drugs Sales by Application (2017-2028)
7.2.2 Europe Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2028)
7.3 Europe Ulcerative Colitis Immunology Drugs Market Size by Country
7.3.1 Europe Ulcerative Colitis Immunology Drugs Sales by Country (2017-2028)
7.3.2 Europe Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ulcerative Colitis Immunology Drugs Market Size by Type
8.1.1 Asia Pacific Ulcerative Colitis Immunology Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Ulcerative Colitis Immunology Drugs Market Size by Application
8.2.1 Asia Pacific Ulcerative Colitis Immunology Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Ulcerative Colitis Immunology Drugs Market Size by Region
8.3.1 Asia Pacific Ulcerative Colitis Immunology Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ulcerative Colitis Immunology Drugs Market Size by Type
9.1.1 Latin America Ulcerative Colitis Immunology Drugs Sales by Type (2017-2028)
9.1.2 Latin America Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2028)
9.2 Latin America Ulcerative Colitis Immunology Drugs Market Size by Application
9.2.1 Latin America Ulcerative Colitis Immunology Drugs Sales by Application (2017-2028)
9.2.2 Latin America Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2028)
9.3 Latin America Ulcerative Colitis Immunology Drugs Market Size by Country
9.3.1 Latin America Ulcerative Colitis Immunology Drugs Sales by Country (2017-2028)
9.3.2 Latin America Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ulcerative Colitis Immunology Drugs Market Size by Type
10.1.1 Middle East and Africa Ulcerative Colitis Immunology Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Ulcerative Colitis Immunology Drugs Market Size by Application
10.2.1 Middle East and Africa Ulcerative Colitis Immunology Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Ulcerative Colitis Immunology Drugs Market Size by Country
10.3.1 Middle East and Africa Ulcerative Colitis Immunology Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen Biotech, Inc.
11.1.1 Janssen Biotech, Inc. Corporation Information
11.1.2 Janssen Biotech, Inc. Overview
11.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Biotech, Inc. Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Overview
11.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Corporation Information
11.3.2 AbbVie Inc. Overview
11.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Inc. Recent Developments
11.4 UCBCares
11.4.1 UCBCares Corporation Information
11.4.2 UCBCares Overview
11.4.3 UCBCares Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 UCBCares Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 UCBCares Recent Developments
11.5 AMGEN
11.5.1 AMGEN Corporation Information
11.5.2 AMGEN Overview
11.5.3 AMGEN Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AMGEN Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AMGEN Recent Developments
11.6 Celltrion Healthcare
11.6.1 Celltrion Healthcare Corporation Information
11.6.2 Celltrion Healthcare Overview
11.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Celltrion Healthcare Recent Developments
11.7 Biogen
11.7.1 Biogen Corporation Information
11.7.2 Biogen Overview
11.7.3 Biogen Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biogen Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biogen Recent Developments
11.8 Genentech USA, Inc.
11.8.1 Genentech USA, Inc. Corporation Information
11.8.2 Genentech USA, Inc. Overview
11.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech USA, Inc. Recent Developments
11.9 ROCHE
11.9.1 ROCHE Corporation Information
11.9.2 ROCHE Overview
11.9.3 ROCHE Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ROCHE Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ROCHE Recent Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Corporation Information
11.10.2 Pfizer Inc. Overview
11.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ulcerative Colitis Immunology Drugs Industry Chain Analysis
12.2 Ulcerative Colitis Immunology Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ulcerative Colitis Immunology Drugs Production Mode & Process
12.4 Ulcerative Colitis Immunology Drugs Sales and Marketing
12.4.1 Ulcerative Colitis Immunology Drugs Sales Channels
12.4.2 Ulcerative Colitis Immunology Drugs Distributors
12.5 Ulcerative Colitis Immunology Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ulcerative Colitis Immunology Drugs Industry Trends
13.2 Ulcerative Colitis Immunology Drugs Market Drivers
13.3 Ulcerative Colitis Immunology Drugs Market Challenges
13.4 Ulcerative Colitis Immunology Drugs Market Restraints
14 Key Findings in The Global Ulcerative Colitis Immunology Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer